Asenapine Maleate is Used for treating manic or mixed episodes associated with bipolar disorder and schizophrenia in adult and pediatric patients. It was first introduced by Allergan Sales Llc in its drug Saphris on Aug 13, 2009. 4 different companies have introduced drugs containing Asenapine Maleate.

Asenapine Maleate Patents

Given below is the list of patents protecting Asenapine Maleate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Saphris	US5763476	Sublingual or buccal pharmaceutical composition	Jun 09, 2020 (Expired)	Allergan
Saphris	US5763476 (Pediatric)	Sublingual or buccal pharmaceutical composition	Dec 09, 2020 (Expired)	Allergan
Saphris	US7741358	Crystal form of asenapine maleate	Apr 06, 2026	Allergan
Saphris	US7741358 (Pediatric)	Crystal form of asenapine maleate	Oct 06, 2026	Allergan
Saphris	US8022228	Crystal form of asenapine maleate	Apr 06, 2026	Allergan
Saphris	US8022228 (Pediatric)	Crystal form of asenapine maleate	Oct 06, 2026	Allergan

Add above patents to watchlist

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Asenapine Maleate's patents.

Latest Legal Activities on Asenapine Maleate's Patents

Given below is the list recent legal activities going on the following patents of Asenapine Maleate.

Event	Date	Patent/Publication
Legal Activities This Week
Payment of Maintenance Fee, 12th Year, Large Entity	08 Feb, 2023	US8022228
Payment of Maintenance Fee, 12th Year, Large Entity	11 Nov, 2021	US7741358
Payment of Maintenance Fee, 8th Year, Large Entity	20 Mar, 2019	US8022228
Payment of Maintenance Fee, 8th Year, Large Entity	22 Dec, 2017	US7741358
Mail-Petition Decision - Accept Late Payment of Maintenance Fees - Granted	25 Jul, 2017	US8022228
Petition Decision - Accept Late Payment of Maintenance Fees - Granted	25 Jul, 2017	US8022228
Petition to Accept Late Payment of Maintenance Fee Payment Filed	25 Jul, 2017	US8022228
Expire Patent	16 Oct, 2015	US8022228
Information Disclosure Statement (IDS) Filed	17 Jul, 2012	US8022228
Recordation of Patent Grant Mailed	20 Sep, 2011	US8022228

Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳